The Orthogonal Bet
Adrian Tchaikovsky on Bio Trajectories and the Importance of Long-Term Thinking
15 Feb 2025
In this episode, host Samuel Arbesman speaks with Adrian Tchaikovsky, the celebrated novelist of numerous science fiction and fantasy books, including his Children of Time series, Final Architects series, and The Doors of Eden. Among many other topics, Adrian’s novels often explore evolutionary history, combining “what-if” questions with an expansive view of the possible directions biology can take, with implications for both Earth and alien life. This is particularly evident in The Doors of Eden, which examines alternate potential paths for evolution and intelligence on Earth.Sam was interested in speaking with Adrian to learn how he thinks about evolution, how he builds the worlds in his stories, and how he envisions the far future of human civilization. They discussed a wide range of topics, including short-term versus long-term thinking, terraforming planets versus altering human biology for space, the Fermi Paradox and SETI, the logic of evolution, world-building, and even how advances in AI relate to science fiction depictions of artificial intelligence.Produced by Christopher GatesMusic by Suno
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare